Atea Pharmaceuticals, Inc. (AVIR) EBIT Margin (2021)
Atea Pharmaceuticals (AVIR) recorded EBIT Margin of 63.06% in Q4 2021, up 130.55 percentage points from the prior quarter.
Powered by 
Analysis
Atea Pharmaceuticals, Inc. (AVIR) EBIT Margin (2021) Analysis & Trends
For FY2021, Atea Pharmaceuticals reported EBIT Margin of 39.38%, up 62.06 percentage points from FY2020.
- Across earlier years, EBIT Margin came in at -22.68% in FY2020.
- Per Business Quant, the preceding three quarters came in at -67.50% (Q3 2021), 14.38% (Q2 2021) and 46.46% (Q1 2021).
Peer Set
Peer Comparison
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2021 | 63.06% |
| Sep 30, 2021 | -67.50% |
| Jun 30, 2021 | 14.38% |
| Mar 31, 2021 | 46.46% |
API Access
Atea Pharmaceuticals, Inc. EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=AVIR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "AVIR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=AVIR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();